Arcellx (ACLX) Tax Provisions (2023 - 2025)

Arcellx's quarterly Tax Provisions came in at $40000.0 in Q4 2025, down 97.34% year-on-year from $1.5 million in Q4 2024, and up 37.93% quarter-over-quarter from $29000.0 in Q2 2025.

Arcellx has reported Tax Provisions for 3 years, with the latest figure at $40000.0 in Q4 2025.

  • For the quarter ending Q4 2025, Tax Provisions fell 97.34% year-over-year to $40000.0; the trailing twelve-month figure through Dec 2025 stood at $69000.0 (down 96.56% YoY), and the FY2025 full-year result was $69000.0, down 96.67% from the prior year.
  • Tax Provisions for Q4 2025 stood at $40000.0, up from $29000.0 in the prior quarter.
  • The five-year high for Tax Provisions was $1.5 million in Q4 2024, with the low at -$282000.0 in Q2 2023.
  • Average Tax Provisions over 3 years is $304111.1, with a median of $200000.0 recorded in 2024.
  • Year-over-year, Tax Provisions surged 3433.33% in 2024 and slumped 97.34% in 2025.
  • Tracing ACLX's Tax Provisions over 3 years: stood at $622000.0 in 2023, then surged by 141.96% to $1.5 million in 2024, then tumbled by 97.34% to $40000.0 in 2025.
  • The last three Tax Provisions figures came in at $40000.0 (Q4 2025), $29000.0 (Q2 2025), and $1.5 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -11.20 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -859,000.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 221.50 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - 216,000.00
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 104.00 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 15.66 Mn
10 Arcellx 6.48 Bn 6.48 Bn - 40,000.00

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 40,000.00
Jun 30, 2025 29,000.00
Dec 31, 2024 1.51 Mn
Sep 30, 2024 200,000.00
Jun 30, 2024 300,000.00
Dec 31, 2023 622,000.00
Sep 30, 2023 -6,000.00
Jun 30, 2023 -282,000.00
Mar 31, 2023 329,000.00